This page includes the latest FDA filings for Alimera Sciences Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | ALIM | DUNS 135745292 |
Device Company | Device | Date |
---|---|---|
Alimera Sciences, Inc. | Prescription Medication | 2024-12-05 |
Alimera Sciences, Inc. | Prescription Medication | 2023-11-08 |
Alimera Sciences, Inc. | Prescription Medication | 2023-10-17 |
Alimera Sciences, Inc. | Prescription Medication | 2023-09-16 |
Alimera Sciences, Inc. | Prescription Medication | 2022-11-18 |
Alimera Sciences, Inc. | Prescription Medication | 2022-01-18 |
Alimera Sciences, Inc. | Prescription Medication | 2019-12-05 |
Alimera Sciences, Inc. | Prescription Medication | 2019-09-11 |
Alimera Sciences, Inc. | Iluvien | 2014-10-15 |
ALIMERA SCIENCES INC | 0000-00-00 00:00:00 |
NCAGE Code | 7AF65 | ALIMERA SCIENCES, INC. |
CAGE Code | 7AF65 | ALIMERA SCIENCES, INC. |
S.A.M. Registration | 7AF65 [135745292] | ALIMERA SCIENCES, INC. |
SEC | 0001267602 | ALIMERA SCIENCES INC |